Find more information and register using this link.

16.30 | Welcome, Ivar Haukeland, Brand Manager, Otsuka Pharma Scandinavia AB
16.35 | Early Nordic experience with AML therapies, Professor Bjørn Tore Gjertsen, Bergen
16.55 | The evolving AML treatment landscape, Professor Gail Roboz, New York.
17.20 | Questions and discussion, led by Professor Bjørn Tore Gjertsen, Bergen